The Impact of Metformin Use on the Cardiovascular Effects of DPP ‐4 Inhibitors: an Analysis of Medicare Claims Data 2007‐2015
ConclusionsIncidence rate differences in multiple cardiovascular outcomes appeared more favorable when DPP ‐4i initiation occurred in the presence of metformin, suggesting a possible interaction between DPP‐4i and metformin.This article is protected by copyright. All rights reserved.
Source: Diabetes, Obesity and Metabolism - Category: Endocrinology Authors: Matthew J. Crowley,
Mugdha Gokhale,
Virginia Pate,
Til St ürmer,
John B. Buse Tags: ORIGINAL ARTICLE Source Type: research
More News: Cardiology | Cardiovascular | Diabetes | Eating Disorders & Weight Management | Endocrinology | Fortamet | Heart | Heart Attack | Medicare | Metformin | Obesity | Statistics | Stroke